Gene Review:
PA3866 - pyocin protein
Pseudomonas aeruginosa PAO1
- Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia. Farkas-Himsley, H., Cheung, R. Cancer Res. (1976)
- Molecular characterization of pyocin S3, a novel S-type pyocin from Pseudomonas aeruginosa. Duport, C., Baysse, C., Michel-Briand, Y. J. Biol. Chem. (1995)
- The structural basis for pyocin resistance in Neisseria gonorrhoeae lipooligosaccharides. John, C.M., Griffiss, J.M., Apicella, M.A., Mandrell, R.E., Gibson, B.W. J. Biol. Chem. (1991)
- PBP3 inhibition elicits adaptive responses in Pseudomonas aeruginosa. Blázquez, J., Gómez-Gómez, J.M., Oliver, A., Juan, C., Kapur, V., Martín, S. Mol. Microbiol. (2006)
- The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage. Nakayama, K., Takashima, K., Ishihara, H., Shinomiya, T., Kageyama, M., Kanaya, S., Ohnishi, M., Murata, T., Mori, H., Hayashi, T. Mol. Microbiol. (2000)
- Ciprofloxacin induction of a susceptibility determinant in Pseudomonas aeruginosa. Brazas, M.D., Hancock, R.E. Antimicrob. Agents Chemother. (2005)
- Pyocin-resistant lipopolysaccharide mutans of Neisseria gonorrhoeae: alterations in sensitivity to normal human serum and polymyxin B. Guymon, L.F., Esser, M., Shafer, W.M. Infect. Immun. (1982)
- Pseudomonas aeruginosa: evidence for the involvement of lipopolysaccharide in determining outer membrane permeability to carbenicillin and gentamicin. Shearer, B.G., Legakis, N.J. J. Infect. Dis. (1985)
- Susceptibility of Pseudomonas aeruginosa of various pyocin types to the newly synthesized ampicillin derivative, N-(6,7-difluoroquinolonyl)ampicillin. Chen, C.H., Tsou, T.L., Chiang, H.Y., Lee, S.H., Lee, F., Lee, J.H., Wang, T.M., Liu, Y.T. J. Antimicrob. Chemother. (1997)
- Dansyl chloride labeling of Pseudomonas aeruginosa treated with pyocin R1: change in permeability of the cell envelope. Uratani, Y. J. Bacteriol. (1982)
- The R-type pyocin of Pseudomonas aeruginosa C is a bacteriophage tail-like particle that contains single-stranded DNA. Lee, F.K., Dudas, K.C., Hanson, J.A., Nelson, M.B., LoVerde, P.T., Apicella, M.A. Infect. Immun. (1999)
- Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections. Beckmann, C., Brittnacher, M., Ernst, R., Mayer-Hamblett, N., Miller, S.I., Burns, J.L. Infect. Immun. (2005)
- Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. Römling, U., Fiedler, B., Bosshammer, J., Grothues, D., Greipel, J., von der Hardt, H., Tümmler, B. J. Infect. Dis. (1994)
- Inhibition of active transport and macromolecular synthesis by pyocin 103 in Neisseria gonorrhoeae. Stein, D.C., Clark, V.L., Young, F.E. Sexually transmitted diseases. (1983)
- Pyocin inhibition of Neisseria gonorrhoeae: mechanism of action. Morse, S.A., Jones, B.V., Lysko, P.G. Antimicrob. Agents Chemother. (1980)
- Pyocin R1 inhibits active transport in Pseudomonas aeruginosa and depolarizes membrane potential. Uratani, Y., Hoshino, T. J. Bacteriol. (1984)
- Colonization of intensive care unit patients by Pseudomonas aeruginosa. Ismaeel, N.A. J. Hosp. Infect. (1993)
- Pyocin sensitivity of Neisseria gonorrhoeae and its feasibility as an epidemiological tool. Sidberry, H.D., Sadoff, J.C. Infect. Immun. (1977)
- Novel resistance to imipenem associated with an altered PBP-4 in a Pseudomonas aeruginosa clinical isolate. Bellido, F., Veuthey, C., Blaser, J., Bauernfeind, A., Pechère, J.C. J. Antimicrob. Chemother. (1990)
- Interaction with lectins and differential wheat germ agglutinin binding of pyocin 103-sensitive and -resistant Neisseria gonorrhoeae. Connelly, M.C., Stein, D.C., Young, F.E., Morse, S.A., Allen, P.Z. J. Bacteriol. (1981)
- Regulation of pyocin genes in Pseudomonas aeruginosa by positive (prtN) and negative (prtR) regulatory genes. Matsui, H., Sano, Y., Ishihara, H., Shinomiya, T. J. Bacteriol. (1993)
- Purification and properties of an S-type pyocin, pyocin AP41. Sano, Y., Kageyama, M. J. Bacteriol. (1981)
- Identification of type II and type III pyoverdine receptors from Pseudomonas aeruginosa. de Chial, M., Ghysels, B., Beatson, S.A., Geoffroy, V., Meyer, J.M., Pattery, T., Baysse, C., Chablain, P., Parsons, Y.N., Winstanley, C., Cordwell, S.J., Cornelis, P. Microbiology (Reading, Engl.) (2003)
- Genetic determinant of pyocin R2 in Pseudomonas aeruginosa PAO. I. Localization of the pyocin R2 gene cluster between the trpCD and trpE genes. Shinomiya, T., Shiga, S., Kageyama, M. Mol. Gen. Genet. (1983)
- Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Jones, A.M., Govan, J.R., Doherty, C.J., Dodd, M.E., Isalska, B.J., Stanbridge, T.N., Webb, A.K. Lancet (2001)
- Phenotypic mixing of pyocin R2 and bacteriophage PS17 in Pseudomonas aeruginosa PAO. Shinomiya, T. J. Virol. (1984)
- Bacteremia due to Pseudomonas aeruginosa: use of a combined typing system in an eight-year study. Conroy, J.V., Baltch, A.L., Smith, R.P., Hammer, M.C., Griffin, P.E. J. Infect. Dis. (1983)
- Oropharyngeal and fecal carriage of Pseudomonas aeruginosa in hospital patients. Murthy, S.K., Baltch, A.L., Smith, R.P., Desjardin, E.K., Hammer, M.C., Conroy, J.V., Michelsen, P.B. J. Clin. Microbiol. (1989)